Literature DB >> 12053279

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

Rossana Berti1, Meghan B Brennan, Samantha S Soldan, Joan M Ohayon, Luca Casareto, Henry F McFarland, Steven Jacobson.   

Abstract

In recent years, human herpesvirus 6 (HHV-6) has been investigated as a possible causative agent for MS. To determine if the detection of HHV-6 DNA in the serum of MS patients correlates with clinical parameters of MS disease progression, a total of 215 serum samples was obtained from 59 MS patients followed prospectively for a 5-month period. These samples were analyzed for the presence of HHV-6 DNA by nested PCR and compared in parallel to MS disease activity. HHV-6 DNA was amplified in 22% (4/18) of samples obtained during a period of clinical exacerbation. Significantly fewer (P = 0.008) sera, 5.6% (11/197), obtained from MS patients during clinical remission tested positive for the presence of HHV-6 DNA. This work demonstrates that the detection of serum HHV-6 DNA is significantly correlated with clinical exacerbations in MS. Moreover, the findings presented in this study have confirmed previous reports supporting an association between MS and HHV-6 and suggest a role for this human herpesvirus in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053279     DOI: 10.1080/13550280290049615-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  31 in total

1.  Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis.

Authors:  N Akhyani; R Berti; M B Brennan; S S Soldan; J M Eaton; H F McFarland; S Jacobson
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Multiple sclerosis and viruses.

Authors:  S D Cook
Journal:  Mult Scler       Date:  1997-12       Impact factor: 6.312

Review 4.  Extended observations on the association of HHV-6 and multiple sclerosis.

Authors:  R Berti; S S Soldan; N Akhyani; H F McFarland; S Jacobson
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

Review 5.  Familial recurrence risks and inheritance of multiple sclerosis.

Authors:  A D Sadovnick
Journal:  Curr Opin Neurol Neurosurg       Date:  1993-04

6.  Genetics and multiple sclerosis: an overview.

Authors:  G C Ebers
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

7.  Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

Authors:  P Sola; E Merelli; R Marasca; M Poggi; M Luppi; M Montorsi; G Torelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

8.  Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients.

Authors:  S S Soldan; T P Leist; K N Juhng; H F McFarland; S Jacobson
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

Review 9.  Human herpesvirus-6.

Authors:  M T Caserta; C B Hall
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

10.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

View more
  28 in total

1.  Detection of HHV-6B in post-mortem central nervous system tissue of a post-bone marrow transplant recipient: a multi-virus array analysis.

Authors:  Karen Yao; Nahid Akyani; Donatella Donati; Naomi Sengamalay; Julie Fotheringham; Elodie Ghedin; Michael Bishop; John Barrett; Fatah Kashanchi; Steven Jacobson
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response.

Authors:  Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

Review 4.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

Review 5.  CD46 plasticity and its inflammatory bias in multiple sclerosis.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-01-26       Impact factor: 4.291

Review 6.  Evidence linking HHV-6 with multiple sclerosis: an update.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Curr Opin Virol       Date:  2014-10-17       Impact factor: 7.090

Review 7.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

8.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

Review 9.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.